The generation of patient-specific induced pluripotent stem cells (iPS cells) is thought to hold great therapeutic potential. Here, somatic cells from Fanconi anaemia patients are reprogrammed to pluripotency after correction of the genetic defect, generating patient-specific iPS cells.
- Ángel Raya
- Ignasi Rodríguez-Pizà
- Juan Carlos Izpisúa Belmonte
